1. Home
  2. FUSE vs RNAZ Comparison

FUSE vs RNAZ Comparison

Compare FUSE & RNAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fusemachines Inc.

FUSE

Fusemachines Inc.

N/A

Current Price

$0.35

Market Cap

28.6M

Sector

Technology

ML Signal

N/A

Logo TransCode Therapeutics Inc.

RNAZ

TransCode Therapeutics Inc.

N/A

Current Price

$1.71

Market Cap

27.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FUSE
RNAZ
Founded
2013
2016
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.6M
27.9M
IPO Year
2025
2021

Fundamental Metrics

Financial Performance
Metric
FUSE
RNAZ
Price
$0.35
$1.71
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 2.6M
28.5K
Earning Date
11-12-2026
08-14-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 96.38
N/A
EPS
★ N/A
N/A
Revenue
★ $7,714,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.32
$1.52
52 Week High
$3.67
$12.69

Technical Indicators

Market Signals
Indicator
FUSE
RNAZ
Relative Strength Index (RSI) 33.69 42.10
Support Level N/A $1.57
Resistance Level $0.65 $1.93
Average True Range (ATR) 0.04 0.16
MACD 0.00 0.04
Stochastic Oscillator 24.85 17.56

Price Performance

Historical Comparison
FUSE
RNAZ

About FUSE Fusemachines Inc.

Fusemachines Inc is a provider of enterprise AI solutions, offering products such as AI Studio, AI Engines, and AI Agents, along with supporting services across various industries. Its solutions are supported by a talent pool from underserved communities, enabling scalable and high-quality AI delivery while promoting access to AI. The Company serves clients across industries, including healthcare, media, technology, and government, helping address challenges such as improving forecasting accuracy, reducing data entry errors, automating recruitment, and detecting fraud. Its product suite includes AI Studio, AI Engines, and AI Agents, designed to build, deploy, and scale AI solutions, and it operates in Nepal and the United States.

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.

Share on Social Networks: